vs
百特国际（BAX）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
百特国际的季度营收约是Roper Technologies的1.3倍（$2.7B vs $2.1B），Roper Technologies净利率更高（15.8% vs -0.6%，领先16.4%），Roper Technologies同比增速更快（11.3% vs 3.0%），Roper Technologies自由现金流更多（$507.0M vs $76.0M），过去两年Roper Technologies的营收复合增速更高（10.5% vs -15.8%）
百特国际是总部位于美国伊利诺伊州迪尔菲尔德的跨国医疗健康企业，业务布局覆盖全球众多市场，专注于研发、生产及销售各类医疗相关产品与解决方案，为全球医疗机构和患者提供专业可靠的医疗支持。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
BAX vs ROP — 直观对比
营收规模更大
BAX
是对方的1.3倍
$2.1B
营收增速更快
ROP
高出8.3%
3.0%
净利率更高
ROP
高出16.4%
-0.6%
自由现金流更多
ROP
多$431.0M
$76.0M
两年增速更快
ROP
近两年复合增速
-15.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.7B | $2.1B |
| 净利润 | $-15.0M | $331.0M |
| 毛利率 | 33.0% | 69.4% |
| 营业利润率 | 2.4% | 27.2% |
| 净利率 | -0.6% | 15.8% |
| 营收同比 | 3.0% | 11.3% |
| 净利润同比 | — | 53.7% |
| 每股收益（稀释后） | $-0.03 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BAXROP
| Q1 26 | $2.7B | $2.1B | ||
| Q4 25 | $3.0B | $2.1B | ||
| Q3 25 | $2.8B | $2.0B | ||
| Q2 25 | $2.8B | $1.9B | ||
| Q1 25 | $2.6B | $1.9B | ||
| Q4 24 | $533.0M | $1.9B | ||
| Q3 24 | $2.7B | $1.8B | ||
| Q2 24 | $3.8B | $1.7B |
净利润BAXROP
| Q1 26 | $-15.0M | $331.0M | ||
| Q4 25 | $-1.1B | $428.4M | ||
| Q3 25 | $-46.0M | $398.5M | ||
| Q2 25 | $91.0M | $378.3M | ||
| Q1 25 | $126.0M | $331.1M | ||
| Q4 24 | $-512.0M | $462.3M | ||
| Q3 24 | $140.0M | $367.9M | ||
| Q2 24 | $-314.0M | $337.1M |
毛利率BAXROP
| Q1 26 | 33.0% | 69.4% | ||
| Q4 25 | 19.4% | 69.5% | ||
| Q3 25 | 33.5% | 69.5% | ||
| Q2 25 | 35.3% | 69.2% | ||
| Q1 25 | 32.8% | 68.7% | ||
| Q4 24 | 25.0% | 68.3% | ||
| Q3 24 | 38.3% | 69.2% | ||
| Q2 24 | 37.5% | 69.5% |
营业利润率BAXROP
| Q1 26 | 2.4% | 27.2% | ||
| Q4 25 | -24.5% | 28.6% | ||
| Q3 25 | 6.1% | 28.4% | ||
| Q2 25 | 6.8% | 28.2% | ||
| Q1 25 | 2.2% | 27.9% | ||
| Q4 24 | -25.5% | 28.0% | ||
| Q3 24 | 5.7% | 28.1% | ||
| Q2 24 | -5.0% | 28.8% |
净利率BAXROP
| Q1 26 | -0.6% | 15.8% | ||
| Q4 25 | -37.9% | 20.8% | ||
| Q3 25 | -1.6% | 19.8% | ||
| Q2 25 | 3.2% | 19.5% | ||
| Q1 25 | 4.8% | 17.6% | ||
| Q4 24 | -96.1% | 24.6% | ||
| Q3 24 | 5.2% | 20.8% | ||
| Q2 24 | -8.2% | 19.6% |
每股收益（稀释后）BAXROP
| Q1 26 | $-0.03 | $4.87 | ||
| Q4 25 | $-2.21 | $3.97 | ||
| Q3 25 | $-0.09 | $3.68 | ||
| Q2 25 | $0.18 | $3.49 | ||
| Q1 25 | $0.25 | $3.06 | ||
| Q4 24 | $-0.99 | $4.29 | ||
| Q3 24 | $0.27 | $3.40 | ||
| Q2 24 | $-0.62 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $382.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | — | $18.8B |
| 总资产 | — | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资BAXROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $2.0B | $297.4M | ||
| Q3 25 | $1.7B | $320.0M | ||
| Q2 25 | $1.7B | $242.4M | ||
| Q1 25 | $2.3B | $372.8M | ||
| Q4 24 | $1.8B | $188.2M | ||
| Q3 24 | $1.4B | $269.6M | ||
| Q2 24 | $2.1B | $251.5M |
总债务BAXROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $9.5B | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $10.4B | $7.6B | ||
| Q3 24 | $10.4B | — | ||
| Q2 24 | $10.4B | — |
股东权益BAXROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $6.1B | $19.9B | ||
| Q3 25 | $7.2B | $20.0B | ||
| Q2 25 | $7.3B | $19.6B | ||
| Q1 25 | $7.1B | $19.2B | ||
| Q4 24 | $7.0B | $18.9B | ||
| Q3 24 | $7.9B | $18.5B | ||
| Q2 24 | $7.6B | $18.1B |
总资产BAXROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $20.1B | $34.6B | ||
| Q3 25 | $21.1B | $34.6B | ||
| Q2 25 | $21.0B | $33.2B | ||
| Q1 25 | $21.3B | $31.4B | ||
| Q4 24 | $25.8B | $31.3B | ||
| Q3 24 | $26.7B | $31.6B | ||
| Q2 24 | $26.3B | $29.8B |
负债/权益比BAXROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | 1.55× | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | 0.40× | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | $76.0M | $507.0M |
| 自由现金流率自由现金流/营收 | 2.8% | 24.2% |
| 资本支出强度资本支出/营收 | 5.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BAXROP
| Q1 26 | — | — | ||
| Q4 25 | $584.0M | $738.0M | ||
| Q3 25 | $237.0M | $869.5M | ||
| Q2 25 | $217.0M | $404.1M | ||
| Q1 25 | $-193.0M | $528.7M | ||
| Q4 24 | $488.0M | $722.2M | ||
| Q3 24 | $253.0M | $755.4M | ||
| Q2 24 | $115.0M | $384.1M |
自由现金流BAXROP
| Q1 26 | $76.0M | $507.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率BAXROP
| Q1 26 | 2.8% | 24.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度BAXROP
| Q1 26 | 5.1% | 0.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率BAXROP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | 2.38× | 1.07× | ||
| Q1 25 | -1.53× | 1.60× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | 1.81× | 2.05× | ||
| Q2 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
